论文部分内容阅读
我院于1985年11月～1986年8月应用河南浙川制药厂制成的盐酸氟桂嗪治疗脑动脉硬化症154例,用桂利嗪做对照71例。疗效良好,现报告如下: 一般资料治疗组154例中,男128例,女26例。年龄40～68岁(平均59.7±SD4.89)。病程2个月～25年(平均2.95±SD 0.54年)。其中单纯脑动脉硬化症70例,合并椎动脉供血不足者16例,颈动脉系供血不足者3例,腔隙性脑梗塞11例,脑血栓形成48例,帕金森氏综合征1例,假球麻痹3例,梗塞性痴呆2例。对照组71例中男60例,女11例。年龄47～76岁(平均59.36±SD 29.94)。病程6个月～7年(平均1.9±SD 1.9年)。其中单纯脑动脉硬化症30例,合并椎动脉系供血不足者8例,颈动脉系供血不足1例,腔隙性脑梗塞8例,脑血栓形成20例,帕金
Our hospital in November 1985 ~ August 1986 application of Henan Zhejiang Chuan Pharmaceutical Factory made of flunarizine 154 cases of cerebral arteriosclerosis, with cinnarizine 71 cases of control. Good effect, are as follows: General information Treatment group 154 cases, 128 males and 26 females. Age 40 to 68 years (mean 59.7 ± SD4.89). Duration of 2 months to 25 years (mean 2.95 ± SD 0.54 years). Including 70 cases of simple cerebral arteriosclerosis, vertebral artery insufficiency in 16 cases, carotid artery insufficiency in 3 cases, lacunar infarction in 11 cases, cerebral thrombosis in 48 cases, Parkinson’s syndrome in 1 case, match-fixing 3 cases of paralysis, 2 cases of infarction dementia. The control group of 71 patients, 60 males and 11 females. Age 47 to 76 years (mean 59.36 ± SD 29.94). Duration of 6 months to 7 years (mean 1.9 ± SD 1.9 years). Including simple cerebral arteriosclerosis in 30 cases, with vertebral artery insufficiency in 8 cases, carotid artery insufficiency in 1 case, lacunar infarction in 8 cases, cerebral thrombosis in 20 cases, Parkin